U.S. Physical Therapy, Inc. (NYSE:USPH) has recently garnered significant attention from financial analysts, with a consensus “Buy” rating across multiple brokerages. This positive outlook is underscored by an ambitious average 12-month price objective set at $109.00, signaling strong confidence in the company’s future performance. This financial analysis indicates a robust sentiment within the investment community regarding the USPH stock.
The collective assessment from six leading equities research analysts paints a predominantly bullish picture for the company. While one analyst has issued a “hold” rating, the majority have given either a “buy” or “strong buy” recommendation, reinforcing the optimistic analyst ratings surrounding U.S. Physical Therapy. These varied but mostly positive endorsements reflect a thorough evaluation of the firm’s market position and growth prospects.
Several prominent research reports have contributed to this consensus. Barrington Research, for instance, reiterated an “outperform” rating and set a $98.00 price objective, highlighting continued strength. Notably, another firm upgraded U.S. Physical Therapy from a “sell” to a “hold” rating, suggesting an improving outlook. JMP Securities further supported this trend by reaffirming a “market outperform” rating with an even higher $113.00 target price.
Beyond analyst recommendations, institutional investors have also significantly adjusted their positions in U.S. Physical Therapy. Major entities like Vanguard Group Inc., Copeland Capital Management LLC, and Southernsun Asset Management LLC have notably boosted their institutional holdings, collectively demonstrating a strong vote of confidence in USPH’s long-term value. This substantial institutional backing often serves as a key indicator of a company’s perceived stability and growth potential.
From a market performance perspective, USPH shares opened at $70.21 on a recent Thursday, exhibiting the stock’s current trading dynamics. The company’s financial health is further highlighted by a debt-to-equity ratio of 0.32, a current ratio of 1.17, and a quick ratio of 1.17, all suggesting a sound financial structure. With a market capitalization exceeding $1.07 billion, the company presents a compelling profile for investment analysis.
U.S. Physical Therapy’s recent quarterly earnings report revealed a strong financial quarter. The company posted $0.48 EPS, comfortably surpassing analysts’ consensus estimates of $0.46. Revenue for the quarter reached $183.79 million, also exceeding expectations and marking an impressive 18.0% year-over-year increase. These positive USPH earnings underscore the operational efficiency and revenue growth of the company.
In addition to strong earnings, the firm recently declared a quarterly dividend of $0.45, translating to an annualized dividend of $1.80 and offering a dividend yield of 2.6%. This commitment to shareholder returns, reflected in a current dividend payout ratio of 82.57%, makes USPH an attractive option for income-focused investors. The consistent USPH dividends reinforce its financial stability.
U.S. Physical Therapy, Inc. primarily operates outpatient physical therapy clinics, providing essential pre- and post-operative care, treatment for orthopedic disorders, sports-related injuries, and rehabilitation services. Its focus on both physical therapy operations and industrial injury prevention services solidifies its position as a key player in the healthcare stock sector, addressing a broad spectrum of patient needs.
